ISIC Q86 · Suriname · 2 publishers

Healthcare in Suriname

386 verified figures for Suriname, covering 13 indicators from 2 primary sources. Every figure links to the report it came from.

JSON Cite and reuse

386 verified figures Updated 4 Oct 2026 Reviewed 17 Sep 2026 Sources typically refresh annually

Suriname compared

The short version

Key takeaways

Market size and output 3

  1. Current health expenditure (CHE) per capita in Suriname (US$) was 297 USD in 2023 (WHO). WHO ↗ T1 Official
  2. Current health expenditure (CHE) as percentage of GDP in Suriname (%) was 5.41% in 2023 (WHO). WHO ↗ T1 Official
  3. Domestic general government health expenditure as percentage of GDP in Suriname (%) was 3.35% in 2023 (WHO). WHO ↗ T1 Official

Adoption and share 3

  1. DTP3 immunization coverage among 1-year-olds in Suriname (%) was 80% in 2025 (WHO). WHO ↗ T1 Official
  2. Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds in Suriname (%) was 67% in 2025 (WHO). WHO ↗ T1 Official
  3. Measles-containing-vaccine second-dose (MCV2) immunization coverage in Suriname (%) was 52% in 2025 (WHO). WHO ↗ T1 Official

Other measures 4

  1. Life expectancy at birth, total in Suriname (years) was 73.8 years in 2024 (World Bank). World Bank ↗ T1 Official
  2. Adult obesity prevalence in Suriname (age-standardized, %) was 30.8% in 2024 (WHO). WHO ↗ T1 Official
  3. Adult obesity prevalence: female in Suriname (age-standardized, %) was 41% in 2024 (WHO). WHO ↗ T1 Official
  4. Adult obesity prevalence: male in Suriname (age-standardized, %) was 20.4% in 2024 (WHO). WHO ↗ T1 Official

The complete table

Healthcare data for Suriname

Every row links to its own page with the full source, verbatim quote and citation.

386 data points across 13 indicators. Each line shows the latest value; open a line for earlier periods and forecasts.

IndicatorPeriodValueSourceType
Adult obesity prevalence (age-standardized, %)+34 more202430.8%WHOT12024estimate→

All 35 figures for this indicator

Adult obesity prevalence: female (age-standardized, %)+34 more202441%WHOT12024estimate→

All 35 figures for this indicator

Adult obesity prevalence: male (age-standardized, %)+34 more202420.4%WHOT12024estimate→

All 35 figures for this indicator

Current health expenditure (CHE) as percentage of GDP (%)+23 more20235.41%WHOT12023actual→

All 24 figures for this indicator

Current health expenditure (CHE) per capita (US$)+23 more2023297 USDWHOT12023actual→

All 24 figures for this indicator

Domestic general government health expenditure as percentage of GDP (%)+23 more20233.35%WHOT12023actual→

All 24 figures for this indicator

DTP3 immunization coverage among 1-year-olds (%)+25 more202580%WHOT12025estimate→

All 26 figures for this indicator

Life expectancy at birth, total (years)+64 more202473.8 yearsWorld BankT12024estimate→

All 65 figures for this indicator

Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%)+25 more202567%WHOT12025estimate→

All 26 figures for this indicator

Measles-containing-vaccine second-dose (MCV2) immunization coverage (%)+25 more202552%WHOT12025estimate→

All 26 figures for this indicator

NCD mortality rate (per 100,000 population)+21 more2021452.9 per 100,000 peopleWHOT12021estimate→

All 22 figures for this indicator

Premature NCD mortality probability (ages 30–70, %)+21 more202118.7%WHOT12021estimate→

All 22 figures for this indicator

Suicide mortality rate (per 100,000 population)+21 more202122.5 per 100,000 peopleWHOT12021estimate→

All 22 figures for this indicator

Primary documents

Sources

13 primary source documents. Every figure on this page traces to one of these.
Document Publisher Authority tier Accessed Locator Data points
World Bank life expectancy at birth (total, years) Dataset World Bank T1 Official 3 Oct 2026 SP.DYN.LE00.IN: {"countryiso3code":"SUR","date":"2024","indicator.id":"SP.DYN.LE00.IN"}; SP.DYN.LE00.IN: {"countryiso3code":"SUR","date":"2023","indicator.id":"SP.DYN.LE00.IN"}; SP.DYN.LE00.IN: {"countryiso3code":"SUR","date":"2022","indicator.id":"SP.DYN.LE00.IN"} 65
WHO adult obesity prevalence (age-standardized, both sexes) Dataset WHO T1 Official 2 Oct 2026 NCD_BMI_30A: {"Dim1":"SEX_BTSX","SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2024"}; NCD_BMI_30A: {"Dim1":"SEX_BTSX","SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2023"}; NCD_BMI_30A: {"Dim1":"SEX_BTSX","SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2022"} 35
WHO adult obesity prevalence (age-standardized, female) Dataset WHO T1 Official 2 Oct 2026 NCD_BMI_30A: {"Dim1":"SEX_FMLE","SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2024"}; NCD_BMI_30A: {"Dim1":"SEX_FMLE","SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2023"}; NCD_BMI_30A: {"Dim1":"SEX_FMLE","SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2022"} 35
WHO adult obesity prevalence (age-standardized, male) Dataset WHO T1 Official 2 Oct 2026 NCD_BMI_30A: {"Dim1":"SEX_MLE","SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2024"}; NCD_BMI_30A: {"Dim1":"SEX_MLE","SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2023"}; NCD_BMI_30A: {"Dim1":"SEX_MLE","SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2022"} 35
WHO current health expenditure (CHE) as percentage of GDP Dataset WHO T1 Official 2 Oct 2026 GHED_CHEGDP_SHA2011: {"SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2023"}; GHED_CHEGDP_SHA2011: {"SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2022"}; GHED_CHEGDP_SHA2011: {"SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2021"} 24
WHO current health expenditure (CHE) per capita in US$ Dataset WHO T1 Official 2 Oct 2026 GHED_CHE_pc_US_SHA2011: {"SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2023"}; GHED_CHE_pc_US_SHA2011: {"SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2022"}; GHED_CHE_pc_US_SHA2011: {"SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2021"} 24
WHO/UNICEF DTP3 immunization coverage among 1-year-olds Dataset WHO T1 Official 2 Oct 2026 WHS4_100: {"SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2025"}; WHS4_100: {"SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2024"}; WHS4_100: {"SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2023"} 26
WHO domestic general government health expenditure as percentage of GDP Dataset WHO T1 Official 2 Oct 2026 GHED_GGHE-DGDP_SHA2011: {"SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2023"}; GHED_GGHE-DGDP_SHA2011: {"SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2022"}; GHED_GGHE-DGDP_SHA2011: {"SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2021"} 24
WHO/UNICEF MCV1 immunization coverage among 1-year-olds Dataset WHO T1 Official 2 Oct 2026 WHS8_110: {"SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2025"}; WHS8_110: {"SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2024"}; WHS8_110: {"SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2023"} 26
WHO/UNICEF MCV2 immunization coverage by recommended age Dataset WHO T1 Official 2 Oct 2026 MCV2: {"SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2025"}; MCV2: {"SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2024"}; MCV2: {"SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2023"} 26
WHO age-standardized NCD mortality rate (per 100,000 population, both sexes) Dataset WHO T1 Official 3 Oct 2026 WHS2_131: {"Dim1":"SEX_BTSX","SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2021"}; WHS2_131: {"Dim1":"SEX_BTSX","SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2020"}; WHS2_131: {"Dim1":"SEX_BTSX","SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2019"} 22
WHO probability of premature death from four main NCDs (ages 30–70, %) Dataset WHO T1 Official 3 Oct 2026 NCDMORT3070: {"Dim1":"SEX_BTSX","SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2021"}; NCDMORT3070: {"Dim1":"SEX_BTSX","SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2020"}; NCDMORT3070: {"Dim1":"SEX_BTSX","SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2019"} 22
WHO age-standardized suicide mortality rate (per 100,000 population, both sexes) Dataset WHO T1 Official 3 Oct 2026 MH_12: {"Dim1":"SEX_BTSX","SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2021"}; MH_12: {"Dim1":"SEX_BTSX","SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2020"}; MH_12: {"Dim1":"SEX_BTSX","SpatialDim":"SUR","SpatialDimType":"COUNTRY","TimeDim":"2019"} 22

Report snapshots are retained internally for verification only and are never redistributed. Where a figure comes from a paywalled report, only the number published in its public summary is recorded.

All 386 collected records for Suriname are published as verified.

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. Each figure's own page carries APA, MLA, Chicago and BibTeX citations naming its original publisher.

StatOrigin. (2026). Healthcare in Suriname: statistics. Retrieved from https://statorigin.org/industries/healthcare/suriname